The U.S. minimally invasive surgery (MIS) market size was valued at USD 176.38 Billion in 2025 and is expected to reach USD 318.27 billion by 2033, growing at a CAGR of 7.66% from 2025 to 2033. A key factor driving market expansion is the rising prevalence of chronic conditions such as obesity, cardiovascular diseases, and cancer. These conditions often require surgery but benefit from approaches that shorten recovery times and lower complications. Additionally, ongoing innovations in surgical technology-like robotics, high-definition imaging, laparoscopic instruments, and navigation systems-enable surgeons to perform complex procedures more accurately while minimizing patient trauma. Increasing patient awareness about the advantages of minimally invasive techniques has further propelled the demand for these procedures.
Advances in surgical robotics have revolutionized minimally invasive surgery (MIS) by enhancing surgeons’ dexterity, improving visualization (often with 3D imaging), and facilitating more precise movements through small incisions. These benefits lower the barrier of complexity for certain procedures, enabling operations that may have required open surgery to now be performed less invasively. According to the American Hospital Association (AHA), as of 2024, the da Vinci robotic surgical system facilitated around 2.68 million procedures globally, and 2.63 million were carried out in the U.S. As a result, implants such as the da Vinci robot have contributed to an expanded scope of MIS across specialties, including urology, gynecology, general surgery, and more.
Furthermore, evidence from hospital data shows this trend in action. Facilities that introduce robotic-assisted surgery (RAS) capabilities tend to increase their rate of MIS, not merely replacing one minimally invasive method with another but expanding overall usage of less invasive approaches across patient groups. This indicates that RAS does not replace laparoscopic methods for robotic ones; it enables more patients who previously might have undergone open surgery to access the benefits of MIS.
Endoscopic procedures are critical in U.S. healthcare, especially for gastrointestinal diagnosis and treatment. According to several sources, approximately 2.13 million endoscopies were performed in the U.S. in 2023. These high procedure volumes reflect how deeply endoscopy intertwines minimally invasive diagnostic and therapeutic strategies. Colonoscopy remains the cornerstone of cancer prevention programs, with more than 15 million individuals undergoing the procedure annually.
This product will be delivered within 1-3 business days.
Advances in surgical robotics have revolutionized minimally invasive surgery (MIS) by enhancing surgeons’ dexterity, improving visualization (often with 3D imaging), and facilitating more precise movements through small incisions. These benefits lower the barrier of complexity for certain procedures, enabling operations that may have required open surgery to now be performed less invasively. According to the American Hospital Association (AHA), as of 2024, the da Vinci robotic surgical system facilitated around 2.68 million procedures globally, and 2.63 million were carried out in the U.S. As a result, implants such as the da Vinci robot have contributed to an expanded scope of MIS across specialties, including urology, gynecology, general surgery, and more.
Furthermore, evidence from hospital data shows this trend in action. Facilities that introduce robotic-assisted surgery (RAS) capabilities tend to increase their rate of MIS, not merely replacing one minimally invasive method with another but expanding overall usage of less invasive approaches across patient groups. This indicates that RAS does not replace laparoscopic methods for robotic ones; it enables more patients who previously might have undergone open surgery to access the benefits of MIS.
Endoscopic procedures are critical in U.S. healthcare, especially for gastrointestinal diagnosis and treatment. According to several sources, approximately 2.13 million endoscopies were performed in the U.S. in 2023. These high procedure volumes reflect how deeply endoscopy intertwines minimally invasive diagnostic and therapeutic strategies. Colonoscopy remains the cornerstone of cancer prevention programs, with more than 15 million individuals undergoing the procedure annually.
U.S. Minimally Invasive Surgery Market Report Segmentation
This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. minimally invasive surgery (MIS) market report based on surgical specialty, method, payer type, and end-use:Surgical Specialty Outlook (Revenue, USD Million, 2021-2033)
- General Surgery
- Gastrointestinal Surgery
- Gynecological Surgery
- Urological Surgery
- Cardiothoracic Surgery
- Orthopedic & Spine Surgery
- Neurosurgery
- Colorectal Surgery
- Bariatric Surgery
- Vascular & Endoscopic Surgery
- Plastic & Reconstructive Surgery
Method Outlook (Revenue, USD Million, 2021-2033)
- Laparoscopic Surgery
- Thoracoscopic Surgery/VATS
- Robotic-assisted Surgery
- Endoscopic Surgery
- Catheter-based/ Interventional Procedures
- Others
Payer Type Outlook (Revenue, USD Million, 2021-2033)
- Private Health Insurance
- Medicare
- Medicaid
- Out-of-Pocket/ Self-pay
- Other Payers
End-use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Minimally Invasive Surgery (MIS) Market Variables, Trends & Scope
Chapter 4. U.S. Minimally Invasive Surgery (MIS) Market: Surgical Specialty Estimates & Trend Analysis
Chapter 5. U.S. Minimally Invasive Surgery (MIS) Market: Method Estimates & Trend Analysis
Chapter 6. U.S. Minimally Invasive Surgery (MIS) Market: Payer Type Estimates & Trend Analysis
Chapter 7. U.S. Minimally Invasive Surgery (MIS) Market: End-use Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of tables
List of figures
Companies Mentioned
The leading players profiled in this U.S. Minimally Invasive Surgery market report include:- edtronic plc
- ntuitive Surgical
- MR Surgical
- mith & Nephew plc
- enishaw
- onteris Medical
- ROCEPT BioRobotics
- ndoQuest Robotics
- oon Surgical
- sensus Surgical US, Inc.
- lympus Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 125 |
| Published | September 2025 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 176.38 Billion |
| Forecasted Market Value ( USD | $ 318.27 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | United States |
| No. of Companies Mentioned | 12 |
